Delirium and dementia represent two distinct but frequently overlapping cognitive disorders that significantly impact elderly patients. [KEY_CONCEPT] Delirium is an acute, fluctuating disturbance of consciousness and cognition that develops over hours to days, while dementia is a chronic, progressive decline in cognitive function that develops over months to years.
Delirium affects 15-50% of hospitalized older adults and up to 80% of critically ill patients. It is characterized by:
- Acute onset with fluctuating course
- Disturbance of consciousness and attention
- Cognitive changes (memory, orientation, language, perception)
- Evidence of underlying medical cause
Dementia affects approximately 10% of adults over 65 and 32% of those over 85. Major types include:
- Alzheimer's disease (60-70% of cases)
- Vascular dementia (15-20%)
- Lewy body dementia (10-15%)
- Frontotemporal dementia (5-10%)
[HIGH_YIELD] The key epidemiological risk factors for both conditions include advanced age, multiple comorbidities, polypharmacy, and frailty [3]. [CLINICAL_PEARL] Delirium and dementia frequently coexist - patients with baseline dementia have a 2-5 fold increased risk of developing delirium.
Pathophysiology differs significantly between conditions:
- Delirium: Acute disruption of neurotransmitter systems (acetylcholine, dopamine, GABA) due to systemic illness, medications, or metabolic disturbances
- Dementia: Progressive neurodegeneration with protein accumulation (amyloid, tau, alpha-synuclein) leading to synaptic dysfunction and neuronal loss
[KEY_CONCEPT] The economic burden is substantial, with delirium increasing hospital length of stay by 2-3 days and doubling healthcare costs, while dementia care costs exceed $300 billion annually in the United States.